RXL vs. XTJL
Compare and contrast key facts about ProShares Ultra Health Care (RXL) and Innovator U.S. Equity Accelerated Plus ETF - July (XTJL).
RXL and XTJL are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. RXL is a passively managed fund by ProShares that tracks the performance of the Dow Jones U.S. Health Care Index (200%). It was launched on Jan 30, 2007. XTJL is an actively managed fund by Innovator. It was launched on Jul 1, 2021.
Performance
RXL vs. XTJL - Performance Comparison
Loading graphics...
RXL vs. XTJL - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
RXL ProShares Ultra Health Care | -9.67% | 19.76% | -2.72% | -3.15% | -15.26% | 18.08% |
XTJL Innovator U.S. Equity Accelerated Plus ETF - July | -0.71% | 15.42% | 14.43% | 25.72% | -15.66% | 7.28% |
Returns By Period
In the year-to-date period, RXL achieves a -9.67% return, which is significantly lower than XTJL's -0.71% return.
RXL
- 1D
- 1.75%
- 1M
- -12.90%
- YTD
- -9.67%
- 6M
- 4.12%
- 1Y
- 0.69%
- 3Y*
- 4.08%
- 5Y*
- 4.05%
- 10Y*
- 12.77%
XTJL
- 1D
- 0.66%
- 1M
- -1.72%
- YTD
- -0.71%
- 6M
- 1.81%
- 1Y
- 16.00%
- 3Y*
- 14.59%
- 5Y*
- —
- 10Y*
- —
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
RXL vs. XTJL - Expense Ratio Comparison
RXL has a 0.95% expense ratio, which is higher than XTJL's 0.79% expense ratio.
Return for Risk
RXL vs. XTJL — Risk / Return Rank
RXL
XTJL
RXL vs. XTJL - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ProShares Ultra Health Care (RXL) and Innovator U.S. Equity Accelerated Plus ETF - July (XTJL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| RXL | XTJL | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.02 | 0.88 | -0.86 |
Sortino ratioReturn per unit of downside risk | 0.28 | 1.41 | -1.14 |
Omega ratioGain probability vs. loss probability | 1.03 | 1.28 | -0.25 |
Calmar ratioReturn relative to maximum drawdown | -0.10 | 1.18 | -1.28 |
Martin ratioReturn relative to average drawdown | -0.19 | 7.45 | -7.65 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading graphics...
Sharpe Ratios by Period
| RXL | XTJL | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.02 | 0.88 | -0.86 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.14 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.39 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.40 | 0.57 | -0.17 |
Correlation
The correlation between RXL and XTJL is 0.60, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Dividends
RXL vs. XTJL - Dividend Comparison
RXL's dividend yield for the trailing twelve months is around 1.61%, while XTJL has not paid dividends to shareholders.
| TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
RXL ProShares Ultra Health Care | 1.61% | 1.43% | 1.22% | 0.18% | 0.32% | 0.10% | 0.15% | 0.27% | 0.32% | 0.11% | 0.12% | 0.93% |
XTJL Innovator U.S. Equity Accelerated Plus ETF - July | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Drawdowns
RXL vs. XTJL - Drawdown Comparison
The maximum RXL drawdown since its inception was -67.70%, which is greater than XTJL's maximum drawdown of -23.24%. Use the drawdown chart below to compare losses from any high point for RXL and XTJL.
Loading graphics...
Drawdown Indicators
| RXL | XTJL | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -67.70% | -23.24% | -44.46% |
Max Drawdown (1Y)Largest decline over 1 year | -22.73% | -13.81% | -8.92% |
Max Drawdown (5Y)Largest decline over 5 years | -36.08% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -51.00% | — | — |
Current DrawdownCurrent decline from peak | -17.90% | -2.12% | -15.78% |
Average DrawdownAverage peak-to-trough decline | -15.82% | -4.18% | -11.64% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 11.68% | 2.19% | +9.49% |
Volatility
RXL vs. XTJL - Volatility Comparison
ProShares Ultra Health Care (RXL) has a higher volatility of 9.47% compared to Innovator U.S. Equity Accelerated Plus ETF - July (XTJL) at 4.50%. This indicates that RXL's price experiences larger fluctuations and is considered to be riskier than XTJL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading graphics...
Volatility by Period
| RXL | XTJL | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 9.47% | 4.50% | +4.97% |
Volatility (6M)Calculated over the trailing 6-month period | 20.60% | 6.30% | +14.30% |
Volatility (1Y)Calculated over the trailing 1-year period | 35.51% | 18.18% | +17.33% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 29.34% | 15.46% | +13.88% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 33.19% | 15.46% | +17.73% |